Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FTNS8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,928
Award facts
- Contract value 100% obligated
- $23,927.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,927.85 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. This firm fixed-price delivery order, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its capability to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Ozempic, a diabetes medication included in this delivery order, exemplifies the company's role in providing specialized pharmaceutical products to support military healthcare operations. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded with firm fixed pricing, reflecting the company's ability to meet federal procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FTNS8?
SPE2DB25FTNS8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FTNS8 worth?
The government has obligated $23,928 on SPE2DB25FTNS8.
Is contract SPE2DB25FTNS8 an order under another contract?
Yes. SPE2DB25FTNS8 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FTNS8 competed?
The extent of competition for SPE2DB25FTNS8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award